Treatment

Authors: J. McLellan, S. Plevin
Journal: Equine Veterinary Education

Several commercial devices are available to the equine practitioner for preparation of platelet-rich plasma (PRP). PRP is a ‘catch all’ term for a multitude of platelet concentrates (PC) with different biological components and properties. Case reports often fail to cite the exact type of PC used. A critical analysis of the available evidence on the clinical significance of differences between platelet concentrates is presented in an attempt to determine if one commercially available product is superior to the others.

Category: Equine - Treatment
Authors: S. D. GUTIERREZ-NIBEYRO, N. A. WHITE II, N. M. WERPY
Journal: Equine Veterinary Journal

Reasons for performing study: Currently, there are limited data regarding the long-term outcome of horses with foot pain treated with corrective shoeing, rest and rehabilitation, and intrasynovial anti-inflammatory medication to target lesions detected with MRI. Objective: To report the long-term (≥12 months) outcome of horses with foot lesions following medical therapy. Hypotheses: 1) There is no association between clinical parameters considered and a poor response to therapy.

Category: Equine - Lameness - Treatment
Authors: D. J. GUEST, M. R. W. SMITH, W. R. ALLEN
Journal: Equine Veterinary Journal

Reasons for performing study: Injury to the superficial digital flexor tendon (SDFT) is common in racing and sport horses and poor tendon regeneration leads to high reinjury rates. Autologous mesenchymal stromal cells (MSCs) are being used clinically to improve tendon regeneration but they have some practical limitations. Embryonic stem cells (ESCs) may overcome these limitations but their fate following injection into the damaged SDFT is unknown.

Objective: To inject MSCs and ESCs into distinct areas of damage in the SDFT and monitor their survival over a 3 month period.

Authors: C. W. McILWRAITH
Journal: Equine Veterinary Journal

Intra-articular use of corticosteroids has become a recent focus (or re-focus) of attention in the Thoroughbred racing industry. This manuscript reviews the clinical use and scientific basis of intra-articular corticosteroid administration including catastrophic injury, articular cartilage degradation and the development of osteoarthritis (OA), as well as the timing of injection relative to racing.

Authors: Ty W. Wallis DVM, MS, DACVS, Gary M. Baxter VMD, MS, DACVS, Natasha M. Werpy DVM, DACVR, Gary L. Mason DVM, PhD, DACVP, David D. Frisbie DVM, PhD, DACVS and Nicolai Jarloev DVM, PhD
Journal: Journal of Equine Veterinary Science

The objective of the present study was to determine the efficacy of urinary bladder matrix (UBM) in collagenase-induced superficial digital flexor (SDF) tendonitis by using clinical, ultrasonographic, and histologic data. A total of eight healthy adult horses were used in this study. Bilateral forelimb SDF tendonitis was created in the horses by injecting collagenase. After 14 days, one randomly selected forelimb SDF tendon was blindly treated with UBM and the opposite tendon was treated with a control (saline).

Authors: M. R. GOUGH*, D. THIBAUD † and R. K. W. SMITH ‡
Journal: Equine Veterinary Journal

Reasons for performing study: Tiludronate regulates bone remodelling through a decrease of the resorptive process and should therefore ameliorate the remodelling processes active in osteoarthritis of the distal tarsal joints ('bone spavin') and alleviate pain associated with abnormal bone lysis.

Objective: To confirm the efficacy of tiludronate, administered as a single infusion at a dose of 1 mg/kg bwt, in the treatment of bone spavin in the horse.

Authors: Marc Koene, Xavier Goupil, Clemens Kampmann, Peter D. Hanson, Davida Denton, Matthias G. Pollmeier
Journal: Journal of Equine Veterinary Science

The objective was to generate evidence for clinical efficacy and acceptability of a second generation coxib, firocoxib, administered orally for 14 days to lame horses under field conditions compared with a classic nonsteroidal anti-inflammatory drug, vedaprofen, in a prospective, randomized, controlled, double-blinded, multicenter field trial. Ninety-six client-owned horses with American Association of Equine Practitioners score of at least grade 3 lameness or grade 2 lameness plus at least a score of 2 for either pain on palpation, range of motion, or joint swelling were analyzed.

Category: Equine - Lameness - Treatment
Authors: M. E. ÁLVAREZ, C. E. GIRALDO and J. U. CARMONA
Journal: Equine Veterinary Journal

Reasons for performing study: There is a growing interest in the use of autologous platelet concentrates (PCs) as treatment for chronic musculoskeletal diseases in horses. However, there is no information on the risk of bacterial contamination during their preparation.

Category: Equine - Treatment
Authors: SPENCER M. BARBER, DVM, Diplomate ACVS 1 , LUCA PANIZZI, Dr Med Vet 1 , and HAYLEY M. LANG 1
Journal: Veterinary Surgery

Objective—To evaluate arthrodesis as a treatment for carpometacarpal joint osteoarthritis (CMC-OA).

Study Design—Case series.

Animals—Horses (n=12) with CMC-OA.

Methods—Arthrodesis was facilitated by insertion and fanning of a drill bit into the CMC joint at several (3–5) locations in 15 limbs. Follow-up radiographs were obtained for 7 horses (9 limbs). Outcome was determined by telephone survey of owners based on postoperative pain, return to use, appearance of the limb, and success of treatment.

Authors: Mary Boyce, DVM, MS; Erin D. Malone, DVM, PhD; Lorraine B. Anderson, PhD; Seijin Park, PhD; Sandra M. Godden, DVM; Florien Jenner, DVM; Troy N. Trumble, DVM, PhD
Journal: American Journal of Veterinary Research

Objective—To determine whether triamcinolone acetonide diffuses from the distal interphalangeal joint (DIPJ) to the navicular bursa, diffusion is direct or systemic, and addition of sodium hyaluronan has an effect on diffusion in horses.

Animals—11 adult horses without forelimb lameness.

Category: Equine - Lameness - Treatment